NCT06592716View on ClinicalTrials.gov

Can Recurrence of Cancer in the Oropharynx Be Detected by Blood Samples?

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Oropharyngeal Squamous Cell Carcinoma (SCC)Oropharynx CancerOropharynx Cancer, MetastaticOropharynx Cancer, RecurrentOropharyngeal Carcinoma
Interventions
DIAGNOSTIC_TEST

Liquid biopsy

The intervention is a liquid biopsy as a blood sample taken in a peripheral vein. The blood samples are analyzed for cell free HPV-DNA.

Trial Locations (1)

Unknown

RECRUITING

Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen

All Listed Sponsors
collaborator

Copenhagen University Hospital, Denmark

OTHER

collaborator

Department of Otorhinolaryngology, Head and Neck Surgery and Audiology

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER